Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Steven Neier is listed as Principal at Binney Street Capital at Dana-Farber Cancer Institute, a with 5752 employees, based in Boston, Massachusetts, United States. AeroLeads shows a matched LinkedIn profile for Steven Neier.
Steven Neier previously worked as Principal, Binney Street Capital, Venture Capital at Dana-Farber Cancer Institute and Business Development Associate at Dana-Farber Cancer Institute. Steven Neier holds Doctor Of Philosophy (Ph.D.), Immunology from Mayo Graduate School.
This section adds company-level context without repeating Steven Neier's masked contact details.
Review company-level records connected to Steven Neier before choosing the right outreach path.
Steven Neier is a Principal at Binney Street Capital at Dana-Farber Cancer Institute.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Boston, Massachusetts, United States
Binney Street Capital is Dana-Farber’s first-ever venture fund that will capitalize on investment opportunities in startup companies that were created either with Dana-Farber intellectual property or were co-founded by a Dana-Farber investigator.
• Identify and develop business and partnering opportunities between Dana-Farber investigators and biopharma / investors• Manage Dana-Farber’s innovative venture-philanthropy collaboration with MPM Capital• Oversee Dana-Farber’s Pipeline Accelerator Program which financially supports the advancement of high-impact science to de-risk, increase the value, and accelerate commercialization of Dana-Farber technologies.
NextRNA is transforming the non-coding RNA therapeutic space and is shifting the concept of undruggable into druggable. NextRNA is based on unique platform that I helped co-develop in the Novina lab.
Microbial Machines is developing synthetically engineered bacteria to specifically detect and treat diseases of the alimentary track.
Laboratory of Dr. Carl Novina with co-mentorship by Entrepreneur-in-Residence, Fred Mermelstein PhD• Shaped the scientific direction of lab research and led efforts relating to the commercialization of platform technologies• Managed the development and execution of research programs and supported their growth through conception of and writing federal, foundation, and commercial award applications • Led diligence and commercialization efforts on platform technologies to strengthen IP position and secure a major biopharmaceutical partnership
Greater Boston Area
Greater Boston Area
Sunnyvale, Ca
QuantumCyte pioneered QCPRECISE, an automated tissue dissection and AI integrated platform to modernize pathology and improve patient outcomes
Rochester, Minnesota Area
Laboratory of Dr. Adam Schrum and Dr. Claudia NeuhauserI developed a highly-sensitive, multiplexed, microsphere-based platform to measure protein-protein interactions. I identified dysregulated signaling pathways and novel signatures in autoimmune patient T cells (Science Signaling, 2016) and mechanistically demonstrated that quantitative proximal signaling (and not qualitative different signals) specify thymic selection outcomes (Science Immunology, 2019).
Other employees you can reach at dana-farber.org. View company contacts for 5752 employees →
Kevin Panaro
Colleague at Dana-Farber Cancer InstituteBrookline, Massachusetts, United States
View →
XC
Xueying Chen
Colleague at Dana-Farber Cancer InstituteBoston, Massachusetts, United States
View →
ND
Nakul Desai
Colleague at Dana-Farber Cancer InstituteGreater Boston, United States
View →
SR
Shayne Redmond
Colleague at Dana-Farber Cancer InstituteGreater Boston, United States
View →
SM
Suada Mehic
Colleague at Dana-Farber Cancer InstituteRevere, Massachusetts, United States
View →
DU
Denise Undefined
Colleague at Dana-Farber Cancer InstituteUnited States
View →
JM
Jeannette Mejia
Colleague at Dana-Farber Cancer InstituteBoston, Massachusetts, United States
View →
LH
Laura Hicks
Colleague at Dana-Farber Cancer InstituteMelrose, Massachusetts, United States
View →
AM
Adela M.
Colleague at Dana-Farber Cancer InstituteGreater Boston, United States
View →
HM
Hugo Medeiros
Colleague at Dana-Farber Cancer InstituteProvidence, Rhode Island, United States
View →
Quick answers generated from the profile data available on this page.
Steven Neier works for Dana-Farber Cancer Institute.
Steven Neier is listed as Principal at Binney Street Capital at Dana-Farber Cancer Institute.
Steven Neier is based in Boston, Massachusetts, United States while working with Dana-Farber Cancer Institute.
Steven Neier has worked for Dana-Farber Cancer Institute, Nextrna Therapeutics, Microbial Machines, Dana-Farber Cancer Institute & Harvard Medical School, and Quantumcyte, Inc..
Steven Neier's colleagues at Dana-Farber Cancer Institute include Kevin Panaro, Xueying Chen, Nakul Desai, Shayne Redmond, and Suada Mehic.
You can use AeroLeads to view verified contact signals for Steven Neier at Dana-Farber Cancer Institute, including work email, phone, and LinkedIn data when available.
Steven Neier holds Doctor Of Philosophy (Ph.D.), Immunology from Mayo Graduate School.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contactsCheck these profiles if this is not the Steven Neier you were looking for.
View similar profiles
